First of all, instead of the measured docetaxel response in prostate cancer patients, we utilized the docetaxel sensitivity score imputed using patients’ RNAseq data to perform the correlation between GAS5 expression and docetaxel response. The gene discussed is GAS5; the disease is Familial prostate cancer.